TOL-3021
Diabetes vaccine trial posts positive results
June 28, 2013Research and Development, Sales and Marketing TOL-3021, Vaccine, diabetes
A groundbreaking new study suggests that the body’s immune system can be taught to reverse the effects of type 1 …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
